Indeed, low-dose AVP infusion is helpful to restore vascular tone, with catecholamine-sparing ability in septic patients, and additional beneficial effects have been observed with selepressin (a selective V1A receptor agonist) in both a relevant preclinical model of sepsis and septic shock patients [24, 25]. This evidence concerns the gene AVP and Sepsis.